Total : 62 View more »
Sigma-Aldrich has announced the launch of a life science-focused application for the social media site, Facebook.
http://www.pharmaasia.com/article-8094-sigmaaldrichlaunchesapplicationonfacebook-asia.html
Sigma-Aldrich to Present at the NASDAQ OMX 23rd Investor Program on Tuesday, December 1, 2009.
Sigma-Aldrich (NASDAQ: SIAL) announced it will host a technical webcast that examines Molecular Self-Assembly (MSA) technology for nanoscale patterning and for biochip arrays useful in high throughput medical diagnosis.
Agreement Provides Researchers With Global Access to Organic Semiconductors Used in Solar Cells, RFID Tags and Flexible Displays
Total : 46 View more »
ST. LOUIS, Nov 24, 2009 /PRNewswire-FirstCall via COMTEX/ --
Sigma-Aldrich Corporation (Nasdaq: SIAL) will be presenting at the NASDAQ OMX conference on Tuesday, December 1st at 1:45 PM GMT in London, 7:45 AM US/CST. Interested parties may listen via live audio broadcast over the Internet available at http://investor.sigmaaldrich.com/. Users can click the "Webcast" icon to access this file.
About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its chemical and biochemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 38 countries and has 7,800 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at http://www.sigma-aldrich.com.
SOURCE Sigma-Aldrich Corporation
http://www.sigma-aldrich.com
Tags: biotechnology conference government london manufacturing nasdaq pharmaceuticals products research science university web
Companies: Sigma-Aldrich Corp. (SIAL)
Nov 21, 2009 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend, our proprietary pattern recognition system, called an Uptrend for Sigma-Aldrich (NASDAQ:SIAL) on July 01, 2009 at $50.42.
Since then, Sigma-Aldrich has returned 7% as of Friday's recent price of $53.94. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nasdaq profit securities trial
Companies: Sigma-Aldrich Corp. (SIAL)
ST. LOUIS, Nov 18, 2009 /PRNewswire-FirstCall via COMTEX/ --
Sigma-Aldrich(R) (Nasdaq: SIAL) today announced the launch of a unique life science-focused application for the social media site, Facebook. Developed and marketed by Sigma(R) Life Science, the 'What's Your Favorite Gene?' application is the first and currently only application of its kind available on Facebook, and provides a platform that can enable scientists and researchers to network with each other and facilitate discussion based on their favorite genes, identifiable via gene functionality and biological pathways. The application also allows researchers to post and share gene information using gene details and associated pathways and interactors from Sigma-Aldrich's award-winning online search platform, 'Your Favorite Gene powered by Ingenuity' (http://www.sigma.com/yfg).
Designed to encourage a culture of scientific collaboration, information sharing, cooperation and networking, the 'What's Your Favorite Gene?' application encourages scientists to become 'fans' of their favorite genes and then connect with colleagues to share their own experiences with the genes that drive their research. In addition, those using the application can build their own scientific profile and pull any online publications into this
profile or pull citations directly from PubMed(R) to create a page that highlights their research accomplishments and provides their skill set and experience. An element of the application is the 'What Gene Are You?' quiz that allows users to determine what gene most accurately portrays their personality.
"With over half a million users worldwide interested in science, including around 200,000 that are researchers or that are interested in Biology, Facebook provides an outstanding platform to connect scientists and a significant audience for Sigma-Aldrich to interact," said Dr. David Smoller, President of Sigma-Aldrich's Research Biotech business unit. "The 'Your Favorite Gene' portal provides the scientific basis for that connection and we hope 'What's Your Favorite Gene?' fosters a culture of information exchange and collaboration within the life science community. We plan to continue expanding the online dialogue of researchers and will be developing additional ways to connect scientists in the coming months."
The biological information that supports the 'What's Your Favorite Gene?' Facebook application is provided by Sigma-Aldrich's 'Your Favorite Gene powered by Ingenuity.' Launched in January 2009, 'Your Favorite Gene powered by Ingenuity' has won awards for its interactive nature, setting it apart from static biological search options available in the life science market. 'Your Favorite Gene powered by Ingenuity' contains interactive pathways and gene interaction maps for over 90,000 genes mapped to relevant products such as antibodies, RNA interference (shRNA and siRNA), small molecules, proteins, and peptides. The portal enables researchers to model experiments and to search by gene, protein, function, disease, species, tissue or pathway by providing access to a curated database of biological information.
To find out more about the YFG Facebook application, visit http://apps.facebook.com/yourfavoritegene/. For further information about the Your Favorite Gene powered by Ingenuity online search platform, visit http://www.sigma.com/yfg.
About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 38 countries and has 7,800 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning website at http://www.sigma-aldrich.com.
Sigma-Aldrich and Sigma are trademarks of Sigma-Aldrich Biotechnology L.P. and Sigma-Aldrich Co. Facebook is a registered trademark of Facebook Inc. PubMed is a registered trademark of the National Library of Medicine.
SOURCE Sigma-Aldrich
http://www.sigma-aldrich.com
Tags: biology biotechnology business community disease government library manufacturing market media medicine nasdaq networking online pharmaceuticals president products research science species university
Companies: Sigma-Aldrich Corp. (SIAL)
Nov 11, 2009 (Datamonitor Financial Deals Tracker via COMTEX) --
Sigma-Aldrich Corporation has entered into an exclusive worldwide distribution agreement with Stemgent, Inc., to offer Stemgent's portfolio of lentivirus-based delivery systems for the generation of induced pluripotent stem cells. Both the companies are based in the US.
Sigma-Aldrich is a producer and marketer of biochemicals, organic and inorganic chemicals, and related products, while Stemgent is a provider of reagents and tools for stem cell scientists and laboratories.
Deal Type Partnership Sub-Category Acquisition of Rights,Distribution Deal Status Announced: 2009-11-10
Deal Participants
Partner 1 (Company) Sigma-Aldrich Corporation Partner 2 (Company) Stemgent, Inc.
Deal Rationale
This agreement expands Sigma-Aldrich's portfolio of advanced stem cell research technologies.
Tags: acquisition chemicals partnership products research technology
Companies: Sigma-Aldrich Corp. (SIAL)
Total : 281 View more »
By Fain Hughes, fhughes@knobias.com Sigma-Aldrich Corporation (SIAL) and Sangamo BioSciences, Inc. (SGMO) announced a major expansion of their existing license agreement to include the exclusive rights to develop and distribute zinc finger DNA binding protein (ZFP)-modified cell lines for
We appreciate the fact that you are taking the time to learn more about the company, its technologies, applications, value proposition, and the people that make up the Rubicon Team.
Sigma-Aldrich offers the GenElute HP 96-Well Plasmid Miniprep Kit for DNA purification,.a 96-well kit that provided rapid purification of plasmid DNA.
...ST. LOUIS Oct. 20 /- Sigma-Aldrich® (Nasd...The partner program managed by Sigma Advanced Genetic Engineering (SA...Partners will be asked to conduct their own evaluation studies and pro... The real value of our knockout rat models will lie in the phenotypes
Total : 2,280,000 View more »
Produces and sells a broad range of biochemicals, organic and inorganic chemicals and related products. Parent company of Sigma, Aldrich, Fluka and Supelco.
Sigma-Aldrich Corporation NASDAQ: SIAL, is a life science and high technology company with over 8,000 employees and operations in 37 countries [1]
United States Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic ...
See the company profile for Sigma-Aldrich Corporation (SIAL) including business summary, industry/sector information, number of employees, business summary, corporate governance ...
Content Copyright 2008 - Sigma-Aldrich / Supelco Sigma-Aldrich / Supelco is a RenewableEnergyWorld.
http://www.renewableenergyworld.com/rea/partner/events?cid=6987